2020
Search results
Emmanuelle Marie Charpentier (French pronunciation: [emanɥɛl maʁi ʃaʁpɑ̃tje]; born 11 December 1968) is a French professor and researcher in microbiology, genetics, and biochemistry. As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin .
Emmanuelle Charpentier is Director and Scientific Member at the Max Planck Unit for the Science of Pathogens.
Emmanuelle Charpentier. The Nobel Prize in Chemistry 2020. Born: 11 December 1968, Juvisy-sur-Orge, France. Affiliation at the time of the award: Max Planck Unit for the Science of Pathogens, Berlin, Germany. Prize motivation: “for the development of a method for genome editing” Prize share: 1/2. Work.
Jun 11, 2024 · Emmanuelle Charpentier is a French scientist who discovered, with American biochemist Jennifer Doudna, a molecular tool known as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9. Their discovery of CRISPR-Cas9 in 2012 laid the foundation for gene editing.
Oct 7, 2020 · Emmanuelle Charpentier and Jennifer Doudna share the award for developing the precise genome-editing technology.
Emmanuelle Charpentier was awarded the Nobel prize in Chemistry in 2020. She is a world-leading expert in regulatory mechanisms underlying processes of infection and immunity in bacterial pathogens.
Emmanuelle Charpentier and Jennifer Doudna are awarded the Nobel Prize in Chemistry 2020 for discovering one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors. Researchers can use these to change the DNA of animals, plants and microorganisms with extremely high precision.
Telephone interview with Emmanuelle Charpentier following the announcement of the 2020 Nobel Prize in Chemistry on 7 October 2020. The interviewer is Adam Smith, Chief Scientific Officer of Nobel Media.
Apr 27, 2016 · The microbiologist spent years moving labs and relishing solitude. Then her work on gene-editing thrust her into the scientific spotlight. Emmanuelle Charpentier: a key inventor of the gene ...
Emmanuelle is the inventor and co-owner of the core intellectual property of the CRISPR-Cas9 technology. Together with Rodger Novak and Shaun Foy, she co-founded CRISPR Therapeutics and ERS Genomics to develop the CRISPR-Cas genome engineering technology for biotechnology and biomedical applications.
